Juehua Xu

Title: Juehua Xu: Innovator in Antibody Development

Introduction

Juehua Xu is a prominent inventor based in Shanghai, China, known for his significant contributions to the field of biopharmaceuticals. He holds two patents that focus on innovative antibody therapies aimed at improving human health. His work has the potential to revolutionize treatments for coagulation disorders and enhance therapeutic options in immunology.

Latest Patents

One of Juehua Xu's latest patents is titled "Antibody against factor XIa in activated form of coagulant factor XI, preparation method therefor and use thereof." This invention provides an antibody that specifically binds to FXIa, inhibiting the endogenous pathway of human coagulation without affecting the exogenous pathway. This capability can significantly reduce the formation of arteriovenous shunt thrombosis while not increasing bleeding time or volume, positioning it as a potential antithrombotic drug. Another notable patent is "Lymphocyte activation gene-3 (LAG-3) binding antibody and use thereof," which relates to an antibody that binds to LAG-3, offering new avenues for cancer immunotherapy.

Career Highlights

Juehua Xu has worked with notable companies in the biopharmaceutical sector, including Mab-venture Biopharm Co., Ltd. and Mab-legend Biotech Co., Ltd. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in antibody therapies.

Collaborations

Juehua Xu has collaborated with esteemed colleagues such as Shaoxiong Wang and John L Xu. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of biopharmaceutical research.

Conclusion

Juehua Xu's work in antibody development showcases his commitment to advancing medical science and improving patient outcomes. His innovative patents reflect a deep understanding of biochemistry and a dedication to addressing critical health challenges.